Literature DB >> 1545253

Histopathological follow-up study of 66 cerebral arteriovenous malformations after therapeutic embolization with polyvinyl alcohol.

I M Germano1, R L Davis, C B Wilson, G B Hieshima.   

Abstract

Embolization with polyvinyl alcohol (PVA) is an accepted method of rendering complex arteriovenous malformations (AVM's) more amenable to surgery, but its effects on human vascular tissues have not been adequately documented. The authors reviewed the histopathology of 66 intracranial AVM's resected 1 to 76 days after embolization with PVA. The mean age of the patients was 36 years, and their AVM's were located in the cerebral hemispheres (92%), the cerebellum (6%), or the corpus callosum (2%). In 79% of cases, at least one vessel contained PVA particles; in most cases, the vessel was filled with sharp, angular PVA particles in a serpiginous pattern. Polyvinyl alcohol particles indented the endothelium in 69% of cases but were rarely found subendothelially. Clotted blood and fibroblasts were present among the particles, and abundant intraluminal mononuclear and polymorphonuclear inflammatory cells were found in all vessels containing PVA particles. Foreign-body giant cells appeared 2 to 14 days after embolization in the majority of cases. Patchy mural angionecrosis and necrotizing vasculitis were found in 39% of the cases. Recanalized lumina were seen in 18% of PVA-embolized vessels. Foreign materials resembling cotton fibers and other particulate substances, which were probably contaminants of the contrast solution or the embolic material, were found in 65% of the cases. These findings suggest a specific chain of events in the interaction between PVA and vessel wall components and may explain some important sequelae of embolization therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1545253     DOI: 10.3171/jns.1992.76.4.0607

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  21 in total

1.  The utility of the microcrystalline cellulose sphere as a particulate embolic agent: an experimental study.

Authors:  Y Kai; J Hamada; M Morioka; T Todaka; S Hasegawa; Y Ushio
Journal:  AJNR Am J Neuroradiol       Date:  2000 Jun-Jul       Impact factor: 3.825

2.  Cerebral arteriovenous malformations.

Authors: 
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

3.  Treatment of cerebral arteriovenous malformations by neuroradiological intervention and surgical resection.

Authors:  M Westphal; L Cristante; U Grzyska; N Freckmann; F Zanella; H Zeumer; H D Herrmann
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

4.  Endothelial-cell injury of the basilar artery caused by ethanol infusion in dogs.

Authors:  H Kobayashi; H Ide; M Kabuto; Y Handa; T Kubota
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

Review 5.  Advances in Biomaterials and Technologies for Vascular Embolization.

Authors:  Jingjie Hu; Hassan Albadawi; Brian W Chong; Amy R Deipolyi; Rahul A Sheth; Ali Khademhosseini; Rahmi Oklu
Journal:  Adv Mater       Date:  2019-06-06       Impact factor: 30.849

6.  Temperature-sensitive poly(N-isopropylacrylamide-co-butyl methylacrylate) nanogel as an embolic agent: distribution, durability of vascular occlusion, and inflammatory reactions in the renal artery of rabbits.

Authors:  H Zhao; C Zheng; G Feng; Y Zhao; H Liang; H Wu; G Zhou; B Liang; Y Wang; X Xia
Journal:  AJNR Am J Neuroradiol       Date:  2012-08-02       Impact factor: 3.825

7.  Endovascular management of intracerebral and subarachnoid hemorrhage.

Authors:  Franklin A Marden; Soma Sinha Roy
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-07

8.  Application of the liquid coil as an embolic material for arteriovenous malformations.

Authors:  A Kurata; S Suzuki; H Ozawa; I Yuzawa; M Yamda; K Fujii; S Kan; T Kitahara; T Ohmomo; Y Miyasaka
Journal:  Interv Neuroradiol       Date:  2005-10-26       Impact factor: 1.610

9.  A cationic polymer, Eudragit-E, as a new liquid embolic material for arteriovenous malformations.

Authors:  K Yamashita; W Taki; H Iwata; H Kikuchi
Journal:  Neuroradiology       Date:  1996-05       Impact factor: 2.804

Review 10.  The combined management of cerebral arteriovenous malformations. Experience with 100 cases and review of the literature.

Authors:  R Deruty; I Pelissou-Guyotat; C Mottolese; Y Bascoulergue; D Amat
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.